Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
imatinib (gleevec) (2 trials)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)
Leukemia, Myeloid (Phase 2)
Philadelphia Chromosome (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Trials (2 total)
Trial APIs (1 total)